Envestnet Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
55,141
-2,736
-5% -$77K ﹤0.01% 3341
2026
Q1
$1.65M Sell
57,877
-424
-0.7% -$14.5K ﹤0.01% 3142
2025
Q4
$2.31M Buy
58,301
+3,993
+7% +$146K ﹤0.01% 2720
2025
Q3
$1.91M Sell
54,308
-4,152
-7% -$143K ﹤0.01% 2902
2025
Q2
$1.92M Buy
58,460
+1,804
+3% +$58.6K ﹤0.01% 2858
2025
Q1
$1.83M Buy
56,656
+10,570
+23% +$392K ﹤0.01% 2797
2024
Q4
$1.41M Sell
46,086
-2,104
-4% -$67.7K ﹤0.01% 2926
2024
Q3
$1.35M Sell
48,190
-69,526
-59% -$1.71M ﹤0.01% 2917
2024
Q2
$2.68M Sell
117,716
-225
-0.2% -$5.19K ﹤0.01% 2437
2024
Q1
$3.59M Buy
117,941
+1,627
+1% +$54.5K ﹤0.01% 2211
2023
Q4
$4.15M Sell
116,314
-676
-0.6% -$25.1K ﹤0.01% 2016
2023
Q3
$5.12M Buy
116,990
+65,653
+128% +$3.2M ﹤0.01% 1781
2023
Q2
$2.53M Sell
51,337
-2,389
-4% -$110K ﹤0.01% 2135
2023
Q1
$2.23M Buy
53,726
+2,953
+6% +$123K ﹤0.01% 2131
2022
Q4
$2.25M Sell
50,773
-9,758
-16% -$408K ﹤0.01% 2072
2022
Q3
$2.37M Sell
60,531
-596
-1% -$27.3K ﹤0.01% 1983
2022
Q2
$2.5M Buy
61,127
+3,220
+6% +$153K ﹤0.01% 1964
2022
Q1
$3.8M Sell
57,907
-649
-1% -$42.1K ﹤0.01% 1769
2021
Q4
$4.07M Buy
58,556
+2,630
+5% +$191K ﹤0.01% 1709
2021
Q3
$3.89M Buy
55,926
+2,214
+4% +$170K ﹤0.01% 1685
2021
Q2
$4.26M Buy
53,712
+5,146
+11% +$374K ﹤0.01% 1615
2021
Q1
$3.18M Buy
48,566
+30,480
+169% +$1.88M ﹤0.01% 1670
2020
Q4
$1.01M Buy
18,086
+6,712
+59% +$290K ﹤0.01% 2207
2020
Q3
$454K Buy
11,374
+1,289
+13% +$54.7K ﹤0.01% 2513
2020
Q2
$453K Buy
+10,085
New +$439K ﹤0.01% 2475

Other funds holding ATRC

Envestnet Asset Management's ATRC Position: Q2 2026 in Review

Envestnet Asset Management reduced its AtriCure (ATRC) stake by 4.7% in Q2 2026, selling an estimated $77K and leaving 55,141 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3341.

Envestnet Asset Management first reported a position in ATRC in Q2 2020 and has held it in 25 quarters since. The position peaked at $5.12M in Q3 2023. 85 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Envestnet Asset Management held 55,141 shares of AtriCure worth $1.54M as of Q2 2026.
  • Envestnet Asset Management sold 2,736 AtriCure shares in Q2 2026, an estimated $77K.
  • AtriCure made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3341 holding.
  • Envestnet Asset Management first reported a position in AtriCure in Q2 2020 and has held it in 25 quarters since.
  • Envestnet Asset Management's AtriCure position peaked at $5.12M in Q3 2023.
  • 85 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.